Back

Oncostatin M is associated with a higher risk profile and predicts a worse outcome in patients with STEMI

21 March 2026 (16:25 - 17:25)
Organised by: Logo
Congress Presentation Part of: Inflammation, biomarkers, and metabolism in acute coronary syndrome Biomarkers ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Cosme Garcia-Garcia

Germans Trias i Pujol University Hospital, Barcelona (Spain)

5 More presentations in this session

Presentation thumbnail
Change in remnant lipid-inflammatory index predicts long-term outcomes in AMI survivors with achieved LDL-C targets
Professor J. Lee (Daegu, KR)
Abstract
Presentation thumbnail
Adiponectin, leptin, and lipid profiles characterise a meta-bolic high-risk phenotype in ICU patients
Doctor M. Lenz (Vienna, AT)
Abstract
Presentation thumbnail
Inflamatory index in patients with ST-elevation myocardial infarction: a new pronostic tool for cardiogenic shock
Doctor S. Santillan Herrera (Mexico City, MX)
Abstract
Presentation thumbnail
Diagnostic and prognostic evaluation of novel biomarkers compared to esc 0/1-hour and 0/3-hour algorithms in patients with suspected non-ST-elevation myocardial infarction
Doctor M. Yildirim (Heidelberg, DE)
Abstract
Presentation thumbnail
Glycemia as a predictor of acute myocardial infarction severity in non diabetics
Doctor L. Sousa Azevedo (Vila Real, PT) Doctor I. Nobrega Fernandes (Vila Real, PT)
Abstract

Access the full session

Session thumbnail
Inflammation, biomarkers, and metabolism in acute coronary syndrome

The Event

Event poster

ESC Acute CardioVascular Care 2026

21 March 2026 16:25 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources